Kendall Law Group Investigates QuadraMed Corp. on Behalf of Shareholders
08 Dicembre 2009 - 11:41PM
Business Wire
Kendall Law Group, founded by a former federal judge, is
investigating the proposed acquisition of QuadraMed Corp. (NASDAQ:
QDHC) by Francisco Partners. The firm’s investigation concerns
whether the consideration to be paid to shareholders in this
transaction is unfair and substantially below the fair or inherent
value of the company. Also, the investigation will focus on whether
the Board of Directors of QuadraMed may have breached their
fiduciary duties by disregarding the shareholders' interests in not
adequately shopping the Company before entering into the
transaction.
On December 8, 2009, the companies announced that Francisco
Partners will acquire QuadraMed in an all-cash transaction valued
at $126 million. According to the agreement, shareholders will
receive $8.50 per share for QDHC common stock and $13.7097 per
share of Series A Cumulative Mandatory Convertible Preferred Stock.
This represents a 32.6% premium over the $6.41 closing price of
QuadraMed common stock just prior to the announcement, and
approximately 7% over the 52-week high.
If you are a current holder of QDHC and would like additional
information concerning this proposed transaction, including your
rights, contact Hamilton Lindley at 877-744-3728 or by email at
hlindley@kendalllawgroup.com. Kendall Law Group has substantial
experience representing investors in mergers and acquisitions
nationwide. Lawyers at the firm include a former United States
Attorney, federal judicial law clerk, a former state and federal
judge, in addition to experienced securities lawyers.
Grafico Azioni Quadramed Corp (MM) (NASDAQ:QDHC)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Quadramed Corp (MM) (NASDAQ:QDHC)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Quadramed Corp (MM) (NASDAQ): 0 articoli recenti
Più Kendall Law Group Articoli Notizie